Clinical Trials Directory

Trials / Completed

CompletedNCT00657761

Metabolic Effects of Enfuvirtide in Healthy Volunteers

Effect of Enfuvirtide on Lipid and Glucose Metabolism and Mitochondrial Function in Healthy Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The metabolic effects of T-20 are not completely known, since the drug is used in combination with other antiretroviral agents. A short-term study in healthy volunteers, with a double-blind crossover design vs. placebo will illustrate if there may be some direct metabolic effects without the influence of HIV infection and the concurrent use of other drugs.

Conditions

Interventions

TypeNameDescription
DRUGEnfuvirtide90 mg/12h sc for 7 days
DRUGPlacebo0.9% saline solution/12h sc for 7 days

Timeline

Start date
2005-09-01
Primary completion
2006-03-01
Completion
2006-03-01
First posted
2008-04-14
Last updated
2008-04-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00657761. Inclusion in this directory is not an endorsement.